Sanders Capital, LLC Astrazeneca PLC Transaction History
Sanders Capital, LLC
- $68 Billion
- Q4 2024
A detailed history of Sanders Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sanders Capital, LLC holds 15,186,692 shares of AZN stock, worth $1.13 Billion. This represents 1.46% of its overall portfolio holdings.
Number of Shares
15,186,692
Previous 14,974,391
1.42%
Holding current value
$1.13 Billion
Previous $1.17 Billion
14.72%
% of portfolio
1.46%
Previous 1.7%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,341Shares Held
477MCall Options Held
5.39MPut Options Held
3.29M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.68 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.79 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.45 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...